Conference - Atlanta, GA, United States
Recent cancer genome sequencing efforts have revealed that genes involved in chromatin remodeling and epigenetic regulation are frequently and specifically mutated in a wide variety of cancers. While known to serve roles in the control of gene expression and development, these largely unanticipated mutation findings have illuminated newly recognized mechanisms central to the genesis of cancer. Gaining insight into these mechanisms will offer the potential to reveal novel approaches and targets for effective therapeutic intervention. The focus of this Special Conference is to bring together outstanding basic and translational scientists to discuss both their latest findings in the field of chromatin and epigenetic regulation, and how these findings can be used for the development of new therapeutic options for cancer treatment.
(Courtesy of detecting cancer DNA in the blood with genome sequencing technology in a test, via medindia.net)
(Courtesy of Cancer Epigenetics, via invitrogen.com)
Wed, Jun 19, 2013 - Sun, Jun 23, 2013
Loews Atlanta Hotel, Atlanta, GA
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.